Pancreatic Cancer Research

ResearcherYonsei UniversityActive in the last 2 years

Jinsil Seong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1794-5951; OpenAlex author ID A5061503888. Sources: OpenAlex.

Their work

Papers
13 (first author 0, last author 8)
Trials
0
Grants
0
Labs led
1
Collaborators
27
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: 3 papers · 2015: 1 paper · 2016: 1 paper · 2017: 1 paper · 2018: 2 papers · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 2 papers

Papers 13

  1. Reduced Risk of Severe Radiation-Induced Lymphopenia in Carbon Ion Radiation Therapy for Locally Advanced Pancreatic Cancer: A Comparative Analysis of Carbon V… Last author DOI 10.1016/j.ijrobp.2024.04.003↗
  2. Risk Stratification of Pancreatic Ductal Adenocarcinoma Patients Undergoing Curative-Intent Surgery after Neoadjuvant Therapy. Co-author DOI 10.4143/crt.2023.586↗
  3. Significance of lymphocyte recovery from treatment-related lymphopenia in locally advanced pancreatic cancer. Last author DOI 10.1016/j.radonc.2020.07.026↗
  4. A nomogram for predicting survival of patients with locally advanced pancreatic cancer treated with chemoradiotherapy. Last author DOI 10.1016/j.radonc.2018.08.006↗
  5. The Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Are Prognostic Factors in Patients with Locally Advanced Pancreatic Cancer Treated with Chemoradi… Last author DOI 10.5009/gnl17216↗
  6. Dose escalation in locally advanced pancreatic cancer patients receiving chemoradiotherapy. Last author DOI 10.1016/j.radonc.2017.04.010↗
  7. Risk Factors Associated with Loco-Regional Failure after Surgical Resection in Patients with Resectable Pancreatic Cancer. Last author DOI 10.1371/journal.pone.0157196↗
  8. Pathological Complete Remission of Pancreatic Cancer Following Neoadjuvant Chemoradiation Therapy; Not the End of Battles. Co-author DOI 10.1097/md.0000000000002168↗
  9. Clinical usefulness of ¹⁸F-fluorodeoxyglucose-positron emission tomography in patients with locally advanced pancreatic cancer planned to undergo concurrent ch… Last author DOI 10.1016/j.ijrobp.2014.05.030↗
  10. Full-dose gemcitabine is a more effective chemotherapeutic agent than 5-fluorouracil for concurrent chemoradiotherapy as first-line treatment in locally advanc… Co-author DOI 10.1159/000375402↗
  11. Validation of group B borderline resectable pancreatic cancer: retrospective analysis. Co-author DOI 10.5009/gnl13264↗
  12. Gemcitabine based neoadjuvant chemoradiotherapy therapy in patients with borderline resectable pancreatic cancer. Co-author DOI 10.1016/j.pan.2013.07.064↗
  13. High-dose helical tomotherapy with concurrent full-dose chemotherapy for locally advanced pancreatic cancer. Last author DOI 10.1016/j.ijrobp.2011.10.050↗

Closest collaborators

The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Byung Min Lee · 4 shared papers, 2017–2024 · strength 0.62
  2. Chang Moo Kang · 5 shared papers, 2013–2024 · strength 0.40
  3. Seungmin Bang · 5 shared papers, 2013–2024 · strength 0.39
  4. Si Young Song · 7 shared papers, 2012–2016 · strength 0.31
  5. Jee Suk Chang · 5 shared papers, 2012–2018 · strength 0.30
  6. Woong Sub Koom · 2 shared papers, 2012–2024 · strength 0.28
  7. Myeong‐Jin Kim · 2 shared papers, 2015–2024 · strength 0.26
  8. Seung Woo Park · 4 shared papers, 2013–2018 · strength 0.25
  9. Tetsuro Isozaki · 1 shared paper, 2024 · strength 0.24
  10. Gowoon Yang · 1 shared paper, 2024 · strength 0.24
  11. Makoto Shinoto · 1 shared paper, 2024 · strength 0.24
  12. Shigeru Yamada · 1 shared paper, 2024 · strength 0.24
  13. Mi‐Suk Park · 1 shared paper, 2024 · strength 0.21
  14. Hyun Kyung Yang · 1 shared paper, 2024 · strength 0.21
  15. Woo Jung Lee · 4 shared papers, 2013–2016 · strength 0.19
  16. Seung Yeun Chung · 2 shared papers, 2017–2018 · strength 0.19
  17. Kyong Joo Lee · 2 shared papers, 2017–2018 · strength 0.19
  18. Seo Hee Choi · 2 shared papers, 2014–2018 · strength 0.18
  19. Jeong Youp Park · 4 shared papers, 2013–2014 · strength 0.16
  20. Ho Kyoung Hwang · 3 shared papers, 2013–2016 · strength 0.15
  21. Moon Jae Chung · 3 shared papers, 2013–2014 · strength 0.12
  22. Tak Geun Oh · 2 shared papers, 2014 · strength 0.08
  23. Hyun Ju Kim · 1 shared paper, 2016 · strength 0.07
  24. Sung Hwan Lee · 1 shared paper, 2015 · strength 0.05
  25. Huapyong Kang · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.